(Q45055700)

9 December 2017

title

Comparative in vitro activity of clarithromycin. Spanish Collaborative Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1468430

29 September 2022

1 reference

5

R. Cantón

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1468430

29 September 2022

author name string

E. Loza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1468430

29 September 2022

J. Martínez Beltrán

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1468430

29 September 2022

F. Baquero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1468430

29 September 2022

A. León

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1468430

29 September 2022

B. Garijo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1468430

29 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1468430

29 September 2022

publication date

1 September 1992

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

9 December 2017

published in

1 reference

9 December 2017

volume

11

1 reference

9 December 2017

issue

9

1 reference

9 December 2017

page(s)

856-866

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01960892

9 December 2017

exact match

0 references

cites work

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

1 reference

https://api.crossref.org/works/10.1007%2FBF01960892

In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01960892

In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01960892

Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01960892

In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01960892

Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01960892

Comparative in vitro potencies of nine new macrolides.

21 January 2018

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Effect of p H on the Activity of Erythromycin Against 500 Isolates of Gram-Negative Bacilli

1 reference

PubMed

12 December 2020

Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic.

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.1007/BF01960892

1 reference

Dimensions Publication ID

9 December 2017

1028360457

0 references

1 reference